Literature DB >> 27830005

Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition.

Rui Ma1, Jiang Chen2, Shaojie Jiang3, Shuang Lin2, Xiuming Zhang4, Xiao Liang2.   

Abstract

Dysregulation of N-acetyltransferase 10 (NAT10) is associated with the development of many types of tumors; however, its role in hepatocellular carcinoma (HCC) has not been fully elucidated. Here, we examined the role of NAT10 during epithelial-to-mesenchymal transition (EMT) in HCC and established its role in metastasis. We evaluated expression of NAT10 expression in four HCC cell lines and determined the effects of knockdown by siRNA or treatment with the NAT10 inhibitor, Remodelin. NAT10 was highly expressed in HCC cell lines with a mesenchymal-like phenotype (SNU387 and SNU449). Knockdown or inhibition of NAT10 resulted in diminished cell invasion and migration. Moreover, decreased levels of NAT10 were correlated with increased E-cadherin expression and down regulation of vimentin, both of which are canonical markers of EMT signaling, suggesting that NAT10-promoted metastasis may be mediated by EMT in HCC. Our data suggests that up regulation of NAT10-promoted metastasis of HCC cells may be mediated by EMT.

Entities:  

Keywords:  E-cadherin; N-acetyltransferase 10; epithelial-to-mesenchymal transition; hepatocellular carcinoma; vimentin

Year:  2016        PMID: 27830005      PMCID: PMC5095314     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  25 in total

1.  GSK-3β-regulated N-acetyltransferase 10 is involved in colorectal cancer invasion.

Authors:  Hong Zhang; Wei Hou; Hua-Li Wang; Hai-Jing Liu; Xin-Ying Jia; Xing-Zheng Zheng; Yong-Xin Zou; Xin Li; Lin Hou; Michael A McNutt; Bo Zhang
Journal:  Clin Cancer Res       Date:  2014-06-30       Impact factor: 12.531

Review 2.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

Review 3.  The Wnt signaling pathway and its role in tumor development.

Authors:  B Lustig; J Behrens
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-18       Impact factor: 4.553

4.  Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

Authors:  Ghassan K Abou-Alfa; Philip Johnson; Jennifer J Knox; Marinela Capanu; Irina Davidenko; Juan Lacava; Thomas Leung; Bolorsukh Gansukh; Leonard B Saltz
Journal:  JAMA       Date:  2010-11-17       Impact factor: 56.272

5.  Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT.

Authors:  Junjie Lv; Haijing Liu; Qiang Wang; Zhiwei Tang; Lin Hou; Bo Zhang
Journal:  Biochem Biophys Res Commun       Date:  2003-11-14       Impact factor: 3.575

Review 6.  Cadherins and epithelial-to-mesenchymal transition.

Authors:  Alexander Gheldof; Geert Berx
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 7.  Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment.

Authors:  Gianluigi Giannelli; Bhavna Rani; Francesco Dituri; Yuan Cao; Giuseppe Palasciano
Journal:  Gut       Date:  2014-07-21       Impact factor: 23.059

8.  DNA damage induces N-acetyltransferase NAT10 gene expression through transcriptional activation.

Authors:  Haijing Liu; Yun Ling; Yilei Gong; Ying Sun; Lin Hou; Bo Zhang
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

9.  NGF increases VEGF expression and promotes cell proliferation via ERK1/2 and AKT signaling in Müller cells.

Authors:  Jing Wang; Chang He; Tian Zhou; Zijing Huang; Lingli Zhou; Xialin Liu
Journal:  Mol Vis       Date:  2016-03-25       Impact factor: 2.367

Review 10.  Cancer metastases: challenges and opportunities.

Authors:  Xiangming Guan
Journal:  Acta Pharm Sin B       Date:  2015-09-08       Impact factor: 11.413

View more
  14 in total

1.  [Expression of MIER3 in colorectal cancer and bioinformatic analysis of MIER3- interacting proteins].

Authors:  Wen Song; Man Peng; Shi-Yu Duan; Chuang Lin; Qiong Xu; Jun Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

2.  Inhibition of N-acetyltransferase 10 using remodelin attenuates doxorubicin resistance by reversing the epithelial-mesenchymal transition in breast cancer.

Authors:  Ji Wu; Hong Zhu; Jianqiang Wu; Wei Chen; Xiaoqing Guan
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

3.  MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance.

Authors:  Qinggui Chen; Li Lin; Boliang Xiong; Wensheng Yang; Junli Huang; Huibo Shi; Zhenfa Wang
Journal:  J Gastrointest Oncol       Date:  2021-10

4.  Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors.

Authors:  Barbara R Tschida; Nuri A Temiz; Timothy P Kuka; Lindsey A Lee; Jesse D Riordan; Carlos A Tierrablanca; Robert Hullsiek; Sandra Wagner; Wendy A Hudson; Michael A Linden; Khalid Amin; Pauline J Beckmann; Rachel A Heuer; Aaron L Sarver; Ju Dong Yang; Lewis R Roberts; Joseph H Nadeau; Adam J Dupuy; Vincent W Keng; David A Largaespada
Journal:  Cancer Res       Date:  2017-10-09       Impact factor: 12.701

5.  Long non-coding RNA SUMO1P3 may promote cell proliferation, migration, and invasion of pancreatic cancer via EMT signaling pathway.

Authors:  Chuang Tian; Yong Jin; Songshan Shi
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

6.  Cytosolic THUMPD1 promotes breast cancer cells invasion and metastasis via the AKT-GSK3-Snail pathway.

Authors:  Xiupeng Zhang; Guiyang Jiang; Mingfang Sun; Haijing Zhou; Yuan Miao; Mengyuan Liang; Enhua Wang; Yong Zhang
Journal:  Oncotarget       Date:  2017-02-21

7.  CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis.

Authors:  Zhao-Xiong Zhang; Wan-Ni Zhang; Yuan-Yuan Sun; Yun-Hui Li; Zhen-Ming Xu; Wei-Neng Fu
Journal:  Onco Targets Ther       Date:  2018-03-08       Impact factor: 4.147

8.  Matching tRNA modifications in humans to their known and predicted enzymes.

Authors:  Valérie de Crécy-Lagard; Pietro Boccaletto; Carl G Mangleburg; Puneet Sharma; Todd M Lowe; Sebastian A Leidel; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2019-03-18       Impact factor: 16.971

9.  Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression.

Authors:  Taek-In Oh; Yoon-Mi Lee; Beong-Ou Lim; Ji-Hong Lim
Journal:  Int J Mol Sci       Date:  2017-09-07       Impact factor: 5.923

Review 10.  Disruption of the RNA modifications that target the ribosome translation machinery in human cancer.

Authors:  Maxime Janin; Laia Coll-SanMartin; Manel Esteller
Journal:  Mol Cancer       Date:  2020-04-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.